TNDM
Tandem Diabetes Care, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders -20.0% ·
aandelenstroom +0.7% ·
netto nieuwe posities -20.0%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 34.13K | $534,998 | n/a | −2 |
| Q2 2026 | 94 | -3 | 42.93M | $644.94M | +8 | −12 |
| Q1 2026 | 101 | +1 | 46.93M | $900.01M | +9 | −9 |
| Q4 2025 | 101 | +3 | 51.29M | $1.10B | +5 | −1 |
| Q3 2025 | 16 | -4 | 31.69M | $384.56M | n/a | −4 |
| Q2 2025 | 17 | +2 | 28.59M | $532.96M | +3 | −1 |
| Q1 2025 | 12 | -2 | 7.22M | $138.30M | n/a | −2 |
| Q4 2024 | 14 | -1 | 8.91M | $320.82M | n/a | −1 |
| Q3 2024 | 14 | +1 | 9.24M | $392.07M | +1 | n/a |
| Q2 2024 | 13 | n/a | 10.47M | $421.99M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 12.10M | +11.3% | $146.91M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passief) | 7.06M | -4.2% | $85.75M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 2.67M | +0.8% | $32.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.60M | -0.5% | $19.41M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Goldman Sachs Group ✦ | 1.43M | n/a | $17.38M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Baillie Gifford ✦ | 1.12M | -0.5% | $13.60M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 7 | Two Sigma Investments ✦ | 1.12M | -9.4% | $13.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 877.22K | +159.0% | $10.65M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Fidelity (FMR) ✦ | 870.12K | +65.8% | $10.56M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 10 | Morgan Stanley ✦ | 737.55K | n/a | $8.95M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 11 | JPMorgan Chase ✦ | 718.14K | n/a | $8.72M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 12 | Millennium Management ✦ | 705.90K | -27.2% | $8.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 415.14K | +912.5% | $4.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 14 | Renaissance Technologies ✦ | 161.50K | -52.8% | $1.96M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 65.80K | +11.2% | $799,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 39.80K | -88.7% | $483,184 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Capital World Investors | $14.30M | was 0.0% |
| Adage Capital Partners | $4.66M | was 0.0% |
| Gotham Asset Management | $1.54M | was 0.0% |
| Arrowstreet Capital | $231,341 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 51.40K aandelen, $985 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.